Abstract
Anticoagulation therapy with warfarin is essential for postoperative management in patients with left ventricular assist device (LVAD). In this manuscript, we report the case of a patient who developed warfarin resistance after LVAD implantation. Although we administered a novel anticoagulant drug in addition to warfarin and aspirin therapy, the patient developed a major stroke. The patient needed continuous intravenous heparinization until heart transplantation for approximately 2 years. Meticulous management of anticoagulation therapy is essential for a LVAD with warfarin resistance. To our best knowledge, our case is the first case of warfarin resistance in a patient with LVAD.
Similar content being viewed by others
References
Wever-Pinzon O, Naka Y, Garan AR, Takeda K, Pan S, Takayama H, et al. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. J Heart Lung Transplant. 2016;35:884–92.
Topkara VK, Knotts RJ, Jennings DL, Garan AR, Levin AP, Breskin A, et al. Effect of CYP2C9 and VKORC1 gene variants on warfarin response in patients with continuous-flow left ventricular assist devices. ASAIO J. 2016;62:558–64.
KE OS, Meany B, Hurley JP. Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve. Int J Cardiol. 2015;188:63–4.
Yasar AS, Balbay Y, Maden O, Sasmaz H. Early mechanical mitral valve thrombosis in a patient with warfarin resistance. J Heart Valve Dis. 2007;16:200–2.
Loebstein R, Dvoskin I, Halkin H, Vecsler M, Lubetsky A, Rechavi G, et al. A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance. Blood. 2007;109:2477–80.
Gellatly RM. Intravenous warfarin as an alternative for anticoagulation. Pharmacotherapy. 2007;27:933–5.
Terrovitis JV, Ntalianis A, Kapelios CJ, Vakrou S, Diakos N, Katsaros L, et al. Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device. Hellenic J Cardiol. 2015;56:20–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Yoshioka, D., Toda, K., Hidaka, T. et al. Anticoagulation therapy for a LVAD patient with acquired warfarin resistance. J Artif Organs 20, 260–262 (2017). https://doi.org/10.1007/s10047-017-0947-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10047-017-0947-8